Gyeonggi-do, South Korea

Donghoon Yu

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Lead Discovery Center Gmbh, Qurient Co., Ltd., Qurient Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donghoon Yu. Retrieved from https://idiyas.com/inventor/donghoon-yu-63atynxr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Inventor Donghoon Yu: Innovating in Pharmaceutical Chemistry**

Introduction

Donghoon Yu is a notable inventor based in Gyeonggi-do, South Korea, recognized for his contributions to the field of pharmaceutical chemistry. With a focus on developing selective inhibitors for cyclin-dependent kinases, he has garnered a total of two patents that are making strides in medical science.

Latest Patents

Donghoon Yu's latest patents highlight his innovative work with pyrazolo-triazine and pyrazolo-pyrimidine derivatives as selective inhibitors of cyclin-dependent kinase. The first patent relates to these derivatives and their pharmaceutically acceptable salts, which are intended for use as active agents in the prevention and treatment of various diseases, including cell proliferative, inflammatory, immunological, cardiovascular, and infectious diseases. Additionally, this invention also encompasses pharmaceutical compositions containing these compounds.

The second patent delves deeper into substituted pyrazolo derivatives as CDK inhibitors, again focusing on their therapeutic potential for the same spectrum of diseases and outlining their formulations in pharmaceutical preparations.

Career Highlights

Throughout his career, Donghoon Yu has collaborated with various prominent organizations. He has worked with Qurient Co., Ltd., a company aiming to revolutionize drug development, and Lead Discovery Center GmbH, which focuses on translating scientific discoveries into therapeutic innovations. His experience in these organizations has contributed significantly to his inventive capabilities and insights into the pharmaceutical landscape.

Collaborations

In addition to his work at leading companies, Donghoon has collaborated with other talented professionals in his field, including Kiyean Nam and Jaeseung Kim. These collaborations have fostered innovation and have played a critical role in his research and developmental processes.

Conclusion

Donghoon Yu stands out as a pioneering inventor whose work has implications for treating a wide array of diseases. His patented innovations not only reflect his deep understanding of pharmaceutical chemistry but also his commitment to advancing medical treatments. With continued research and development, Donghoon Yu is poised to make further significant contributions to the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…